Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial. (Q54196115)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial. |
scientific article |
Statements
Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial. (English)
Peter A Fasching
1 reference
Sibylle Loibl
1 reference
Michael Untch
1 reference
Volkmar Müller
Stephan Gade
Bettina Steinbach
Gunter von Minckwitz
Kathrin Schwedler
Kristina Lübbe
Christian Schem
Christine Mau
Klaus Pantel
Heidi Schwarzenbach
3 August 2014
147
1
61-68